Biogen Idec: Tecfidera not cause of patient's death

Biogen Idec said the death of a patient in July was not caused by its MS drug Tecfidera, reported the Wall Street Journal, which says the patient's physician came to this conclusion.

The patient had taken Tecfidera but stopped her regimen two-and-a-half weeks before she died, due to side effects including vomiting and diarrhea. Biogen Idec told Pharmalot at the time that this was important to note because the death was not “GI related.”

You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.